We are live on
!
Find out more
B
Braidwell Portfolio holdings
AUM
$3B
1-Year Est. Return
46.72%
This Fund
S&P 500
This Quarter
Est. Return
-7.84%
1 Year Est. Return
+46.72%
3 Year Est. Return
+56.07%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$3.19B
AUM Growth
+$85M
(+2.7%)
Cap. Flow
-$861M
Cap. Flow
% of AUM
-27.01%
Top 10 Holdings %
Top 10 Hldgs %
36.68%
Holding
89
New
17
Increased
26
Reduced
11
Closed
10
Top Buys
| 1 |
CG Oncology
CGON
|
+$75.5M |
| 2 |
Spyre Therapeutics
SYRE
|
+$67.4M |
| 3 |
EXAS
Exact Sciences
EXAS
|
+$62.8M |
| 4 |
Inspire Medical Systems
INSP
|
+$52.6M |
| 5 |
Xenon Pharmaceuticals
XENE
|
+$50.1M |
Top Sells
| 1 |
Transmedics
TMDX
|
+$50.9M |
| 2 |
Vaxcyte
PCVX
|
+$27.5M |
| 3 |
Cullinan Oncology
CGEM
|
+$22.7M |
| 4 |
TRML
Tourmaline Bio
TRML
|
+$20.8M |
| 5 |
argenx
ARGX
|
+$20.2M |
Sector Composition
| 1 | Healthcare | 60.98% |
| 2 | Consumer Staples | 0.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Neurocrine Biosciences
NBIX
$17.3B
| $104M | 3.28% |
759,009
+28,800
| +4% | +$3.95M |
|
|
2
CG Oncology
CGON
$6.44B
| $104M | 3.28% |
3,309,507
+2,179,272
| +193% | +$75.5M |
|
|
3
Xenon Pharmaceuticals
XENE
$6.55B
| $99.8M | 3.13% |
2,560,573
+1,252,562
| +96% | +$50.1M |
|
4
Apogee Therapeutics
APGE
$10.2B
| $94.1M | 2.95% |
2,392,042
+549,527
| +30% | +$26.7M |
|
5
Guardant Health
GH
$21.6B
| $81.1M | 2.54% |
2,807,968
+331,164
| +13% | +$7.71M |
|
6
Legend Biotech
LEGN
$4.46B
| $74M | 2.32% |
1,669,720
+425,925
| +34% | +$19.6M |
|
|
7
argenx
ARGX
$54B
| $71.8M | 2.25% |
166,924
-52,900
| -24% | -$20.2M |
|
8
Align Technology
ALGN
$13B
| $66.4M | 2.08% |
275,207
+105,955
| +63% | +$29.5M |
|
9
Maravai LifeSciences
MRVI
$1.04B
| $64.6M | 2.03% |
9,024,037
+1,802,077
| +25% | +$15.6M |
|
|
10
Vaxcyte
PCVX
$8.19B
| $61M | 1.91% |
808,303
-404,400
| -33% | -$27.5M |
|
|
11
Spyre Therapeutics
SYRE
$8.86B
| $59.1M | 1.85% |
2,514,538
+1,999,538
| +388% | +$67.4M |
|
12
Glaukos
GKOS
$9.21B
| $58.8M | 1.84% |
496,576
+45,900
| +10% | +$4.87M |
|
13
Viking Therapeutics
VKTX
$4.39B
| $58.7M | 1.84% |
1,106,905
+393,805
| +55% | +$25.8M |
|
14
iRhythm Holdings
IRTC
$3.72B
| $56.7M | 1.78% |
526,357
+43,100
| +9% | +$4.4M |
|
|
15
Inspire Medical Systems
INSP
$1.46B
| $50.8M | 1.59% |
379,443
+277,951
| +274% | +$52.6M |
|
|
EXAS
16
DELISTED
Exact Sciences
EXAS
| $48.2M | 1.51% |
+1,141,678
| New | +$62.8M |
|
17
Keros Therapeutics
KROS
$218M
| $44.9M | 1.41% |
982,209
+244,830
| +33% | +$13.2M |
|
18
Intuitive Surgical
ISRG
$138B
| $44.7M | 1.4% |
100,500
| – | – |
|
|
DAWN
19
DELISTED
Day One Biopharmaceuticals
DAWN
| $41.8M | 1.31% |
3,035,904
+862,200
| +40% | +$12.6M |
|
20
Repligen
RGEN
$8.35B
| $40.8M | 1.28% |
323,509
+180,673
| +126% | +$28.3M |
|
|
AVDL
21
DELISTED
Avadel Pharmaceuticals
AVDL
| $40.8M | 1.28% |
2,898,639
+230,090
| +9% | +$3.75M |
|
22
Thermo Fisher Scientific
TMO
$199B
| $39M | 1.22% |
70,449
+23,300
| +49% | +$13.3M |
|
23
Kiniksa Pharmaceuticals
KNSA
$4.75B
| $38.4M | 1.21% |
2,058,303
+665,587
| +48% | +$12.5M |
|
24
Penumbra
PEN
$12.5B
| $38.3M | 1.2% |
212,594
-83,298
| -28% | -$16.6M |
|
25
OrthoPediatrics
KIDS
$507M
| $31.9M | 1% |
1,107,770
| – | – |
|
Similar funds
NC
VVP
SP
DIG
ECP
PCM
ROTUOC
SM